Skip to main content
. Author manuscript; available in PMC: 2014 Jun 25.
Published in final edited form as: Cancer Gene Ther. 2008 Jul 11;15(12):817–822. doi: 10.1038/cgt.2008.53

Fig. 2.

Fig. 2

UC9 produced AdIFN–CM inhibits the growth of various cancer cells as measured by MTT and is temperature sensitive. A. UC9 bladder cancer cells B. DU145 prostate cancer cells C. ZR75T breast cancer cells D. Partial loss of UC Ad-IFN-CM activity after 30 min exposure to 65°C for 30min and was totally lost by placement at 92°C for 3min.